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1  | INTRODUC TION
The incidence of skin cancer, comprising malignant melanoma, 
basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), 
has increased rapidly in the past decades (Cahoon et al., 2015; Hu 
et al., 2009; Rees et al., 2014). Melanoma is the most aggressive of 
skin cancers although it has a low incidence, while non-melanoma 
skin cancer (NMSC) shows high incidence yet considerably lower 
mortality rates compared to melanoma (Apalla et al., 2017). To date, 
recognized risk factors for melanoma and NMSC include fair skin, 
light-coloured eyes, red hair, freckles and melanocytic naevi as well 
as genetic variants, some of which underlie these skin pigmentation 
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Abstract
Pigmentation characteristics are well-known risk factors for skin cancer. 
Polymorphisms in pigmentation genes have been associated with these traits and 
with the risk of malignancy. However, the functional relationship between genetic 
variation and disease is still unclear. This study aims to assess whether pigmenta-
tion SNPs are associated with pigmentary traits and skin cancer via DNA methyla-
tion (DNAm). Using a meta-GWAS of whole-blood DNAm from 36 European cohorts 
(N = 27,750; the Genetics of DNA Methylation Consortium, GoDMC), we found that 
19 out of 27 SNPs in 10 pigmentation genes were associated with 391 DNAm sites 
across 30 genomic regions. We examined the effect of 25 selected DNAm sites on 
pigmentation traits, sun exposure phenotypes and skin cancer and on gene expres-
sion in whole blood. We uncovered an association of DNAm site cg07402062 with 
red hair in the Avon Longitudinal Study of Parents and Children (ALSPAC). We also 
found that the expression of ASIP and CDK10 was associated with hair colour, mela-
noma and basal cell carcinoma. Our results indicate that DNAm and expression of 
pigmentation genes may play a role as potential mediators of the relationship be-
tween genetic variants, pigmentation phenotypes and skin cancer and thus deserve 
further scrutiny.
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and sun sensitivity phenotypes (Gordon, 2013). Even though there 
are missense and nonsense polymorphisms in pigmentation genes 
strongly associated with skin cancer, particularly in the gene MC1R 
(Nasti & Timares, 2015), it is not fully understood how non-coding 
variation in these genes relates to malignancy.
DNA methylation (DNAm) is an epigenetic modification with 
a prospective role in cancer aetiology. The association of global 
whole-blood DNA hypomethylation with cancer is well known and 
has also been described for melanoma (Cappetta et al., 2015; Shen 
et al., 2017). In addition, recent studies have shown the presence 
of hypomethylation in skin biopsy samples that were exposed to 
sunlight or artificial ultraviolet radiation (Grönniger et al., 2010; 
Holzscheck et al., 2020; Vandiver et al., 2015). Inter-individual 
DNAm variation at specific sites, measured in peripheral blood, has 
been uncovered as a predictor of a number of complex trait risk fac-
tors as well as all-cause mortality (McCartney et al., 2018). DNAm 
has the potential to be used as a molecular biomarker to diagnose 
disease or to assess prognosis in those affected by disease and is a 
promising candidate leading towards the realization of personalized 
medicine (Nikolouzakis et al., 2020).
This study investigated whether DNAm plays a role in the rela-
tionship between genetic variants, pigmentation-related skin cancer 
risk factors and skin cancer. First, we examined the effect of genetic 
variation on DNAm levels in peripheral blood across 10 regions 
robustly associated with pigmentation traits and skin cancer, in 36 
cohorts of European descent. We then analysed the association of 
pigmentation SNP-associated DNAm sites with sun exposure and 
pigmentation phenotypes in participants of the Avon Longitudinal 
Study of Parents and Children (ALSPAC). Finally, using summary 
data-based Mendelian randomization (SMR), we explored whether 
SNP-related DNAm was likely to causally underlie the expression 
Significance
Several genetic variants in pigmentation-related genes 
have been associated with skin cancer, particularly in pop-
ulations of European ancestry. DNA methylation was in-
vestigated as a potential link between pigmentation SNPs, 
pigmentation phenotypes and skin cancer. DNA methyla-
tion sites near MC1R and ASIP were strongly associated 
with pigmentation SNPs, gene expression, hair colour, mel-
anoma and basal cell carcinoma in an analysis that included 
data from the Genetics of DNA Methylation consortium, 
the Avon Longitudinal Study of Parents and Children and 
the UK Biobank. Further evaluation of the role played by 
DNA methylation in these relationships is warranted.
F I G U R E  1   Stages of analysis 
implemented and datasets used in 
this study. From the 391 unique DNA 
methylation (DNAm) sites associated 
with pigmentation SNPs, 25 were 
selected for further analysis as depicted. 
GoDMC, Genetics of DNA methylation 
consortium; ALSPAC, Avon Longitudinal 
Study of Parents and Children; CIT, causal 
inference test; SMR, summary data-based 
Mendelian randomization; eQTL browser, 
blood eQTL browser; CAGE, Cap Analysis 
of Gene Expression; GTEx, Genotype-
Tissue Expression consortium; UKB, UK 
Biobank
• blood DNAm vs 27 pigmentation SNPs
• regression - GoDMC 
• pigmentation/sun exposure traits vs blood DNAm
• regression – ALSPAC
• CIT - ALSPAC
• blood gene expression vs blood DNAm
• SMR – eQTL browser/CAGE/GTEx & McRae et al. (2018)
• pigmentation/sun exposure/skin cancer vs skin gene expression
• SMR – UKB & GTEx
• pigmentation/sun exposure/skin cancer vs blood DNAm
• SMR – UKB & McRae et al. (2018)
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of genes associated with pigmentation phenotypes and skin cancer. 
The purpose of this work was to carry out an integrative analysis to 
evaluate the joint contribution of genetic and epigenetic risk factors 
to skin cancer susceptibility. As this is the first instance of such an 
analysis involving genes associated with pigmentation traits and skin 
cancer, the clinical relevance of our findings will depend on subse-
quent replication and further investigation of the genes and path-
ways that we described here.
2  | MATERIAL S AND METHODS
The different stages of this study are depicted in Figure 1.
2.1 | Identification of DNAm sites associated with 
pigmentation SNPs
The genetics of DNA methylation consortium (GoDMC) was created 
to study the genetic basis of DNAm variation and bring together 
resources and researchers with expertise in the epigenetics field 
(www.godmc.org.uk). One of its aims was to carry out a meta-GWAS 
of DNAm, as measured on Illumina 450k or EPIC Beadchips. Results 
from a meta-GWAS involving 36 European cohorts (N = 27,750) 
were used here. We provide a brief description of the analysis in the 
Methods S1.
Using GoDMC data, we searched for DNAm sites that were 
strongly associated (p < 1 × 10-5) with well-known pigmentation-re-
lated SNPs previously identified via genome-wide association stud-
ies (GWAS) or candidate gene studies (reviewed in reference Pavan & 
Sturm, 2019), located within the genes (or their surrounding regions) 
ASIP (rs1015362, rs4911414, rs619865), BNC2 (rs2153271), IRF4 
(rs12203592, rs12210050), HERC2 (rs12913832), MC1R (rs1110400, 
rs11547464, rs11648785, rs1805005, rs1805006, rs1805007, 
rs1805008, rs1805009, rs2228479, rs258322, rs4785763, 
rs885479), OCA2 (rs1800401, rs1800407), SLC24A4 (rs12896399), 
SLC24A5 (rs1426654), SLC45A2 (rs16891982, rs28777) and TYR 
(rs1042602, rs1393350).
We uncovered 874 strong SNP-DNAm associations across 30 
genomic regions, which included 391 unique DNAm sites. No data 
were available for SNPs in SLC24A5 and SLC45A2, neither for SNPs 
rs1110400, rs11547464, rs1805006 and rs1805009 in MC1R and 
rs1393350 in TYR. Some of these polymorphisms have low minor 
allele frequencies (MAF) and GoDMC only included SNPs with 
MAF > 1%. The other SNPs may not have been part of the genotyp-
ing platforms, successfully imputed, or strongly associated with any 
DNAm site (p > 1 × 10-5).
Variance in DNAm explained by SNPs was estimated as 
2*β2*MAF*(1 − MAF), where β is the effect size and MAF is the minor 
allele frequency.
Linkage disequilibrium (LD) r2 values were obtained with LDlink 
(https://ldlink.nci.nih.gov/).
2.2 | DNA methylation and pigmentation/sun 
exposure phenotypes in the Avon Longitudinal 
Study of Parents and Children (ALSPAC)
Cohort description and information regarding the collection of 
DNAm data in ALSPAC can be found in the Methods S1.
2.2.1 | Regression analysis
The pigmentation/sun exposure phenotypes evaluated included the 
following: skin reflectance, freckles, moles, sunburning, tanning abil-
ity, hair colour and eye colour. We examined DNAm at the nearest 
time point with respect to when the phenotypes were measured. 
We assessed the association of cord blood DNAm and pigmentation 
traits measured before age 7 [i.e. skin reflectance (49 months), freck-
les (49 and/or 61 months), red hair (15 and 54 months), eye colour 
(54 months), tanning ability (69 months)]; the association of DNAm 
in childhood (~7 years old) with sunburning from birth to age 12, and 
total number of moles at 15 years old; and the association of DNAm 
in adolescence (15–17 years old) with total number of moles at 
15 years old, red hair at 18 years old and tanning ability at ~25 years 
old. Description of most of these phenotypes has been provided in 
an earlier work (Bonilla et al., 2014). Data on hair colour and tanning 
ability in young adults were collected in a recent ALSPAC question-
naire (Life@25+), using the same scales employed in past question-
naires (Bonilla et al., 2014).
We tested the association of SNP-associated DNAm sites with 
pigmentation and sun exposure phenotypes using t tests, one-way 
ANOVA tests, linear and logistic regression models. Regressions 
were adjusted for age, sex and the first 10 genetic principal compo-
nents to account for population stratification. Pairwise correlation 
between DNAm sites was examined in ALSPAC children at age 7. 
All analyses were carried out with the statistical package Stata v15.
2.2.2 | Mediation analysis
The causal inference test (CIT) approach (Millstein et al., 2009), im-
plemented in the R package ‘cit’, was employed to investigate the 
causal direction between pigmentation SNPs, DNAm and red hair 
colour. Regressions were adjusted for sex, age and the top 10 genetic 
principal components.
2.3 | Summary data-based Mendelian 
randomization (SMR)
In order to investigate the potential for DNAm at selected sites to be 
causally related to gene expression and phenotypes such as pigmen-
tation characteristics and skin cancer, we carried out a Mendelian 
randomization analysis with colocalization, implemented in the 
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summary data-based Mendelian randomization (SMR) method (Zhu 
et al., 2016). We used the platform Complex Trait Genetics Virtual 
Lab (CTG-VL, https://genoma.io/; Cuellar-Partida et al., 2019) to run 
the statistical package SMR (Lloyd-Jones et al., 2017; Qi et al., 2018; 
Zhu et al., 2016). This method uses summary data from GWAS, 
mQTL or eQTL studies to distinguish causal or pleiotropic associa-
tions between DNAm and gene expression, or between either of 
these and a phenotype, from a situation where the traits are caused 
by different genetic variants that are in strong LD (see figure 1b of 
Zhu et al., 2016). If the former is true, that is a single genetic vari-
ant underlies DNAm and the other tested phenotype, the traits are 
said to be colocalized. The different SMR analyses run are described 
below. Unless otherwise reported, the SMR analyses p-value thresh-
olds were as follows: p SMR < 5 × 10-7/5x10-6 and p HEIDI ≥ 0.05.
2.3.1 | SMR of whole-blood DNA methylation and 
gene expression
Peripheral blood DNAm summary data were extracted from McRae 
et al. (McRae et al., 2018) while summary data on gene expression in 
blood were obtained from three different sources: the Genotype-Tissue 
Expression consortium (GTEx, https://gtexp ortal.org/home/), Cap 
Analysis of Gene Expression (CAGE; Lloyd-Jones et al., 2017), and the 
blood eQTL browser (https://genen etwork.nl/blood eqtlb rowse r/; Westra 
et al., 2013). All expression datasets used the hg19 genome assembly.
2.3.2 | SMR of gene expression in skin, 
pigmentation/sun exposure traits and skin cancer
We ran SMR to assess the association of gene expression in sun-ex-
posed and sun-unexposed skin, obtained from GTEx, with pigmen-
tary and skin cancer phenotypes.
Data were obtained by CTG-VL from the UK Biobank and trait defi-
nitions can be found in the biobank website (https://www.ukbio bank.
ac.uk/). Pigmentation characteristics analysed were skin colour (UKB 
ID#1717, N = 356,530), ease of skin tanning (#1727, N = 353,697), child-
hood sunburn occasions (#1737, N = 269,734), and black (N = 15,809) 
and blonde (N = 41,178) hair colour (#1747, N = 360,270). We also con-
sidered diagnosed malignant melanoma (#ICD10:C43, N = 1,672, total 
N = 361,194), self-reported malignant melanoma (N = 2,898), self-re-
ported basal cell carcinoma (N = 3,441), self-reported squamous cell 
carcinoma (N = 449; all #20001, total N = 361,141) and having melano-
cytic naevi (#ICD10:D22, N = 3,501 cases, total N = 361,194).
2.3.3 | SMR of whole-blood DNA methylation, 
pigmentation/sun exposure traits and skin cancer
We also investigated the potential colocalization of genetic variants 
underlying DNAm with pigmentation traits and skin cancer. DNAm 
utilized in this analysis was measured in blood (McRae et al., 2018).
2.4 | Heritability of the DNA methylation sites 
associated with pigmentation SNPs
We checked the heritability of DNAm sites using the resource pro-
vided by the Complex Disease Epigenetics Group (www.epige nomic 
slab.com/onlin e-data-resou rces/; Hannon, Knox, et al., 2018) that 
employs twin data to report the variance in whole-blood DNAm ex-
plained by an additive genetic component, a shared environmental 
component and a unique environmental component.
3  | RESULTS
3.1 | Identification of DNA methylation sites 
associated with pigmentation SNPs
We summarized available functional information on the analysed 
SNPs in Table 1.
Pigmentation SNPs that were strongly associated with DNAm 
sites in GoDMC are shown in Table S1.
We selected DNAm sites with the most reliable effects for fur-
ther analysis as follows: sites associated with at least six of the MC1R 
region SNPs, three of the ASIP region SNPs or showing the stron-
gest association with pigmentation SNPs in the other genes tested. 
Additionally, chosen DNAm sites had to display consistent associa-
tions with the allele that increased fair pigmentation for a minimum 
of five out of eight SNPs in MC1R and two out of three SNPs in ASIP 
(i.e. the allele increasing fair pigmentation had to always increase or 
always decrease DNAm at the same site for a majority of the SNPs 
tested in that gene). Finally, DNAm sites had to be associated with 
SNPs in ALSPAC participants consistently across the time points 
where DNAm was measured (i.e. birth, childhood, adolescence, 
pregnancy, middle age). Based on these criteria, we followed up a 
total of 25 DNAm sites: 17 in MC1R, 3 in ASIP and one each in IRF4, 
BNC2, TYR, SLC24A4 and HERC2. DNAm sites that were selected for 
further analysis are shown in Table 2.
3.2 | MC1R
In this gene region, we obtained results for red hair colour loss-of-
function variants (RHC) R151C (rs1805007) and R160W (rs1805008), 
and missense variants (rhc) V60L (rs1805005), V92M (rs2228479) 
and R163Q (rs885479) and for non-coding polymorphisms found 
in GWAS to be associated with pigmentation and melanoma risk 
(rs11648785, rs258322 and rs4785763).
MC1R non-coding polymorphisms and functional variants exhib-
ited the largest number of associations with DNAm sites of all the 
pigmentation genes examined, ranging from 26 (rs1805005) to 163 
(rs2228479; Table 1). Three hundred and twelve unique sites were 
strongly associated with at least one of the MC1R SNPs tested. Of 
these, 131 were associated with just one genetic variant. There was 
     |  5BONILLA et AL.
TA B L E  1   Pigmentation SNPs investigated in GoDMC in association with DNA methylation (DNAm) changes







rs12203592 6p25.3 396321 IRF4 T C 0.188 3 eQTL (sun-exposed skin)
rs12210050 6p25.3 475489 IRF4 T C 0.173 7
rs2153271 9p22.2 16864521 BNC2 T C 0.592 4 eQTL (whole blood)
rs1042602 11q14.3 89011046 TYR A C 0.262 5 NP_000363.1:p.
Ser192Tyr
rs12896399 14q32.12 92773663 SLC24A4 T G 0.468 6




rs1800401 15q13.1 28260053 OCA2 G A 0.946 2 NP_000266.2:p.
Arg305Trp
rs12913832 15q13.1 28365618 HERC2 G A 0.744 3 eQTL (whole blood)
rs258322 16q24.3 89755903 CDK10 A G 0.118 98 eQTL (sun-exposed and 
sun-unexposed skin and 
whole blood)
rs1805005 16q24.3 89985844 MC1R T G 0.121 26 rhc (NP_002377.4:p.
Val60Leu)
rs2228479 16q24.3 89985940 MC1R A G 0.089 163 rhc (NP_002377.4:p.
Val92Met)/eQTL 
(sun-exposed and sun-
unexposed skin and 
whole blood)
rs1805007 16q24.3 89986117 MC1R T C 0.086 97 RHC (NP_002377.4:p.
Arg151Cys)/ eQTL 
(sun-exposed and sun-
unexposed skin and 
whole blood)
rs1805008 16q24.3 89986144 MC1R T C 0.083 97 RHC (NP_002377.4:p.
Arg160Trp)/ eQTL 
(sun-exposed and sun-
unexposed skin and 
whole blood)
rs885479 16q24.3 89986154 MC1R A G 0.105 110 rhc (NP_002377.4:p.
Arg163Gln)/ eQTL (sun-
exposed skin)
rs4785763 16q24.3 90066936 AFG3L1P A C 0.332 104 eQTL/ eQTL (sun-
exposed and sun-
unexposed skin and 
whole blood)
rs11648785 16q24.3 90084561 DBNDD1 C T 0.689 67
rs4911414 20q11.22 32729444 ASIP T G 0.342 24
rs1015362 20q11.22 32738612 ASIP C T 0.727 27 eQTL (sun-exposed and 
sun-unexposed skin and 
whole blood)
rs619865 20q11.22 33867697 EIF6 A G 0.109 29
rs16891982 5p13.2 33951693 SLC45A2 G C 0.938 n/a NP_001012527.2:p.
Leu374Phe
rs28777 5p13.2 33958959 SLC45A2 A C 0.956 n/a
rs1393350 11q14.3 89011046 TYR A G 0.244 n/a
rs1426654 15q21.1 48426484 SLC24A5 A G 0.997 n/a NP_995322.1:p.
Thr111Ala
(Continues)
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overlap between DNAm sites associated with different MC1R SNPs 
(Table S2). Twenty-five DNAm sites were associated with a mini-
mum of 6 of the SNPs with results, while 5 were associated with all 
8 of them. However, not all of these DNAm sites showed a consis-
tent direction of association with the alleles that increase the odds 
of having a fair skin phenotype and being affected by melanoma. 
For instance, full consistency was achieved for MC1R DNAm site 
cg01097406 (i.e. all alleles that are associated with fair skin decrease 
DNAm at this position) and cg07130392, both associated with 7 of 
the 8 SNPs tested, and for cg08845973 and cg09738481, associ-
ated with 6 SNPs.
Interestingly, DNAm sites associated with both RHC vari-
ants, which are located in the first exon of the gene SPIRE2 
(i.e. cg03388025, cg04287289, cg07402062, cg21285383, 
cg26513180), exhibited effects of similar magnitude and direction 
(Figure S1). However, for these same DNAm sites, the association 
with rhc variants rs2228479 and rs885479 occurred in the opposite 
direction to that of the RHCs (Table S1).
Although most associations uncovered were between SNPs and 
DNAm sites in cis, MC1R showed several strong associations in trans 
(Figure 2). Besides associations with more distant DNAm sites on 
chromosome 16 (>1 Mb), we identified associations with sites on 
chromosomes 1, 2, 3, 4, 5, 8, 10, 11, 12 and 13 (Table S1, Figure 2). 
One of the trans sites most frequently associated with MC1R SNPs 
(7 of them, largely in low LD) was cg26114043 located in the gene 
inturned planar cell polarity protein (INTU) on chromosome 4 position 
128,544,375. This gene is related to the processes of keratinocyte 
differentiation and hair follicle morphogenesis (https://www.ncbi.
nlm.nih.gov/gene/27152).
The maximum variance in DNAm explained by a pigmenta-
tion SNP was 24.4% shown by the pair rs2228479-cg09569215. 
Amongst the RHC, the highest R2 was found for rs1805007, which 
explained 17.8% of variation at cg08854185 (Table S1).
3.3 | Other pigmentation genes
The number of SNP–DNAm site associations for the other pigmen-
tation genes examined ranged from 1 (rs1800407 in OCA2) to 29 
(rs619865 in ASIP; Table 1). There were 127 unique DNAm sites as-
sociated with at least one SNP in these 7 genes, while 102 DNAm 
sites were associated with only one polymorphism.
Five different DNAm sites in the ASIP region were associated with 
three SNPs each, whereas one site was associated with 3 SNPs in 
the OCA2/HERC2 region (Table S2). There was no DNAm site over-
lap between SNPs rs12210050 and rs12203592 in IRF4. The only 
fully consistent association between SNPs and DNAm sites was with 
cg01901788, located near ASIP (i.e. for all 3 SNPs the alleles associ-
ated with a fair skin phenotype increased DNAm at this site).
As expected, most associations were in cis, although there were three 
associations in trans in ASIP (distant chromosome 20) and one in BNC2 
(chromosome 1; Table S1, Figure 2). Maximum variance in DNAm ex-
plained by SNPs was: 8.9% (ASIP rs4911414-cg08999081), 8.6% (BNC2 
rs2153271-cg03291755), 5.3% (OCA2 rs1800407-cg20906524), 3.0% 
(TYR rs1042602-cg25941151), 2.7% (IRF4 rs12210050-cg26187313), 
1.7% (HERC2 rs12913832-cg20906524) and 1.3% (SLC24A4 
rs12896399-cg16993582; Table S1).
3.4 | DNA methylation sites and pigmentation/sun 
exposure phenotypes in ALSPAC
Pairwise correlation coefficients (Pearson's) and p-values for DNAm 
sites measured in ALSPAC children at age 7 are shown in Table S3a–c. 
There was moderate to strong correlation between DNAm sites in 
the region that extends from cg04287289 to cg03388025 in MC1R 
(Table S3b), and some moderate correlation was detected between 
DNAm sites in unlinked genetic regions (Table S3a).







rs1805006 16q24.3 89985918 MC1R A C 0.010 n/a RHC (NP_002377.4:p.
Asp84Glu)
rs11547464 16q24.3 89986091 MC1R A G 0.009 n/a RHC (NP_002377.4:p.
Arg142His)
rs1110400 16q24.3 89986130 MC1R C T 0.008 n/a RHC (NP_002377.4:p.
Ile155Thr)
rs1805009 16q24.3 89986546 MC1R C G 0.008 n/a RHC (NP_002377.4:p.
Asp294His)
aIn this study, for simplicity, SNPs on chromosome 16q24.3 are considered part of the MC1R genetic region, and SNPs on chromosome 20q11.22 are 
considered part of the ASIP genetic region. 
bThe effect allele is the allele associated with a lighter skin, hair and eye colour, and skin cancer susceptibility. 
cEffect allele frequency from GoDMC for SNPs with associated DNAm sites. Effect allele frequency from 1,000 Genomes for SNPs not available in 
GoDMC. 
dRHC = high penetrance red hair colour variant, rhc = low penetrance red hair colour variant. eQTL information obtained from the GTEx Portal v8 
release. 
TA B L E  1   (Continued)
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3.4.1 | Regression analysis
When we investigated the association of the selected DNAm sites 
with pigmentation and sun exposure traits in ALSPAC children, we 
found the strongest associations with red hair colour. The most 
robust association with this phenotype was that of cg07402062, 
where redhead children showed lower levels of DNAm at this site 
than non-redhead children (Table S4). This effect was seen with 
cord blood DNAm and red hair at 15 and 54 months (after correc-
tion for multiple testing), as well as with DNAm in adolescence 
and red hair at 18 years old (before correction for multiple test-
ing). Associations with the other traits tested were either weaker 
or absent.
3.4.2 | Mediation analysis
The causal inference test (CIT) showed inconclusive results for SNPs 
rs1805007, rs1805008, rs258322, and rs4785763 (Table S5). There 
was evidence for a mediating effect of DNAm at cg07402062 be-
tween these pigmentation SNPs and red hair colour, as well as for red 
hair as a mediator of the relationship between the pigmentation SNPs 
and DNAm at cg07402062. On the other hand, for variants rs2228479 
and rs885479, we found evidence of a causal effect of DNAm at 
cg07402062 on red hair colour, but not the other way around. Finally, 
rs11648785 appeared to influence both traits independently.
3.5 | Summary data-based Mendelian 
randomization (SMR) of whole-blood DNA 
methylation and gene expression
Out of the 25 DNAm sites under analysis, four (cg01023759, 
cg09738481, cg14091419 and cg26114043) were not present in 
any of the expression datasets used. Since the data sources only in-
cluded variation in cis, cg26114043, located on chromosome 4, was 
left out. The 21 remaining sites showed associations with gene ex-
pression to varying degrees which were, for the most part, consistent 
TA B L E  2   Pigmentation SNP-associated DNA methylation (DNAm) sites selected for follow-up
DNAm site Gene region Gene chr chr position # Associated SNPs
Associated in ALSPAC at 
all time points?
cg26114043 MC1Ra  INTU 4 128544375 7 Y
cg09806625 IRF4 EXOC2 6 611523 1 Y
cg03291755 BNC2 BNC2 9 16868891 1 Y
cg05041596 TYR NAALAD2 11 89867385 1 Y
cg04136915 SLC24A4 intergenic 14 92721383 1 Y
cg14091419 HERC2 HERC2 15 28356810 1 Nb 
cg05504729 MC1R ANKRD11 16 89399490 6 Y
cg08845973 MC1R SPG7 16 89592071 6 Y
cg09738481 MC1R CPNE7 16 89653835 6 Y
cg01097406 MC1R intergenic 16 89675127 7 Y
cg04240660 MC1R CHMP1A 16 89714849 6 Y
cg03605463 MC1R LOC284241 16 89740564 6 Y
cg04287289 MC1R FANCA 16 89883240 6 Y
cg26513180 MC1R FANCA 16 89883248 7 Y
cg07402062 MC1R SPIRE2 16 89894098 7 Y
cg21285383 MC1R SPIRE2 16 89894308 7 Y
cg03388025 MC1R SPIRE2 16 89894329 7 Y
cg01768446 MC1R MC1R 16 89982419 8 Y
cg01023759 MC1R MC1R 16 89983766 8 Y
cg01883217 MC1R DEF8 16 90015832 8 Y
cg05185784 MC1R DEF8 16 90016020 7 Y
cg15936718 MC1R GAS8 16 90088801 7 Y
cg01901788 ASIP MAP1LC3A 20 33145848 3 Y
cg08999081 ASIP PIGU 20 33150536 3 Y
cg21132536 ASIP ACSS2 20 33465180 3 Y
acg26114043 is located on chromosome 4 but it is strongly associated with SNPs on chromosome 16 (MC1R region). 
bcg14091419 was associated with HERC2 SNP rs12913832 in pregnancy and middle-age only. 
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between datasets. Of note were the associations of correlated 
DNAm sites cg03388025, cg04287289, cg07402062, cg21285383 
and cg26513180 with the expression of SPIRE2, cg08845973 with 
SPG7, cg01901788 with NCOA6 and cg21132536 with GGT7. Results 
of this analysis, including total numbers of associations per DNAm 
site and dataset, are shown in Table S6.
3.6 | Summary data-based Mendelian 
randomization (SMR) of gene expression in skin, 
pigmentation/sun exposure traits and skin cancer
We found no evidence of a pleiotropic or causal association between 
gene expression at 16q24.3, 20q11.22, or any of the other pigmen-
tation regions included in this study, and ease of skin tanning, skin 
colour, childhood sunburn occasions, melanocytic naevi and SCC, in 
sun-exposed and sun-unexposed skin.
There was evidence of an association with the same genetic vari-
ant between black hair colour and the expression of genes ASIP and 
FAM83C (20q11.22) in sun-exposed skin and of CDK10 (16q24.3), 
ASIP, NCOA6 (20q11.22) and EXOC2 (6p25.3) in sun-unexposed skin, 
whereas blonde hair colour was associated with the expression of 
ASIP and FAM83C in sun-exposed skin and with NCOA6 and EXOC2 
in sun-unexposed skin. In addition, ASIP gene expression was asso-
ciated with self-reported and diagnosed malignant melanoma, and 
BCC in both skin tissues, and CDK10 was associated with self-re-
ported and diagnosed malignant melanoma, and BCC in unexposed 
skin (Table S7).
When the HEIDI p-value threshold was Bonferroni-corrected 
for multiple testing (instead of being set as ≥ 0.05), additional genes 
showed potential pleiotropic/causal associations with the traits 
of interest, including CPNE7, DBNDD1, DEF8, MC1R, SNAI3-AS1, 
SPATA2L, URAHP in 16q24.3, and EIF6, GGT7, UQCC1 in 20q22.11.
3.7 | Additional summary data-based Mendelian 
randomization (SMR) of whole-blood DNA 
methylation and gene expression
Because the DNAm sites we selected were associated with the ex-
pression of just 5 of the genes identified in the previous step (i.e. 
DBNDD1, DEF8, GGT7, NCOA6, SPATA2L), we searched for additional 
DNAm sites that showed an association with the expression of the 
genes reported above. For CDK10, there was no common colocal-
ized DNAm site across all the datasets, rather associations were evi-
dent with several DNAm sites in the 16q24.3 region. For ASIP and 
FAM83C, there were no data available or no evidence of associa-
tion with DNAm sites, and EXOC2 showed two overlapping associ-
ated DNAm sites between the CAGE and GTEx datasets. Results for 
these and other genes are shown in Table S8.
F I G U R E  2   Circos plot showing 
the relationship between SNPs in 
pigmentation genes and DNA methylation 
(DNAm) sites in cis and trans. The external 
track (light blue) depicts the effect of each 
pigmentation SNP on DNAm (negative in 
red, positive in blue). The internal track 
(pink) depicts the R2 (variance explained) 
values. Information extracted from 
Table S1
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3.8 | Summary data-based Mendelian 
randomization (SMR) of whole-blood DNA 
methylation, pigmentation/sun exposure traits and 
skin cancer
We uncovered 696 DNAm sites associated and colocalized with 
pigmentary and skin cancer traits (Table S9), but of these, only a 
reduced number (n = 18) were associated with gene expression colo-
calizing with these phenotypes (see Table S8). From this set of 18 
DNAm sites, 9 were identified in our original analysis in GoDMC but 
only one (cg01901788) was on the list we followed up (the others 
were associated with three SNPs or less, Table S2). SNPs associated 
with these “mediating” 9 DNAm sites were as follows: rs11648785, 
rs1805008 (R160W), rs2228479 (V92M) and rs4785763 in the 
MC1R region; and rs1015362, rs4911414 and rs619865 in the ASIP 
region (Table 3).
3.9 | Heritability
Nine (38%) of 24 DNAm sites followed up showed a heritability value 
of 80% or more (additive genetic contribution), almost all of these 
are located in MC1R. DNAm site cg01023759 was unavailable in this 
dataset. Median heritability was 63% (IQR 31%, 85%; Table S10). The 
five correlated DNAm sites associated with SPIRE2 expression and 
also with SNPs rs1805007, rs1805008, rs2228479 and rs885479 
showed a heritability higher than 63%.
4  | DISCUSSION
In this study, we reported the existence of strong associations be-
tween pigmentation/sun exposure/skin cancer-associated SNPs and 
DNAm variation at specific sites, mostly in cis, with a few cases in 
trans. This appears to be especially marked in the MC1R gene region, 
which could be related to the high CpG content present in this region 
(Martinez-Cadenas et al., 2013). The SNP-DNAm site associations 
were observed for functional variants (RHC and rhc) as well as for 
non-coding polymorphisms within MC1R.
For a set of selected DNAm sites (those associated with sev-
eral pigmentation SNPs in the same direction), we assessed their 
effect on pigmentation/sun exposure phenotypes measured in 
ALSPAC participants. Although sample sizes were modest, we de-
tected a strong inverse association of red hair with cg07402062, 
which is located in the gene SPIRE2 (MC1R region). Remarkably, a 
recent GWAS of hair colour has identified the strongest genetic 
signal of association with red hair (versus brown/black hair) at SNP 
rs34357723 (T allele associated with red hair; LD with rs1805007, 
r2 = .27), a signal that remained relevant even after adjustment for 
MC1R coding variants (Morgan et al., 2018). Rs34357723 is an in-
tronic variant of SPIRE2, and GoDMC data indicate that it is also a 
strong mQTL for cg07402062, explaining ~16% of DNAm at this site 
(T allele beta = −0.82, SE = 0.01). The CIT analysis suggested that a 
mediation effect of cg07402062 DNAm between rs34357723 and 
red hair colour is compatible with ALSPAC data (see Table S5), al-
though replication of these findings is needed.
Galanter and colleagues reported that DNAm at cg07402062 
and cg21285383 differed between ethnic groups and that these dif-
ferences could be accounted for by differences in genetic ancestry 
(Galanter et al., 2017), which would also be consistent with hair co-
lour variation between groups.
The high heritability detected for these two DNAm sites, along 
with cg03388025, cg04287289 and cg26513180, and their associ-
ation with RHC and rhc variants suggests a close relationship be-
tween SPIRE2 DNAm status and the MC1R gene structure.
SPIRE2 was recently shown to participate in myosin Va-
dependent transport of melanosomes in melanocytes via the gener-
ation of actin tracks (Alzahofi et al., 2018). However, despite SPIRE2 
expression colocalizing with DNAm at cg07402062 and correlated 
sites, we detected no evidence of colocalization with hair colour 
GWAS signals, and thus, we cannot yet conclude that this gene caus-
ally underlies the phenotype.
Using summary data and two-sample Mendelian randomiza-
tion implemented in SMR, we determined that the selected DNAm 
sites affected expression of a number of genes in cis, but there 
was limited overlap between this set of genes and those that 
showed an association of expression with pigmentation traits and 
skin cancer. Given that the DNAm expression analysis was carried 
out using whole-blood data, and the expression-phenotype anal-
ysis used skin data, the differences observed may be due to this 
discrepancy.
Previous reports on DNAm in pigmentation/skin cancer-as-
sociated regions include a study by Roos and colleagues (Roos 
et al., 2017) who showed that DNAm in healthy human skin was 
associated in cis with SNPs underlying melanoma risk discovered 
by GWAS, including two polymorphisms in MC1R (rs258322, 
rs4785763, which we tested) and one in the ASIP region (rs910873, 
not considered by us but in LD with rs619865). SNPs in SLC45A2 
(rs35390) and TYR (rs1393350, rs1847134) were also investigated 
but yielded no evidence of association with DNAm, a finding sim-
ilar to ours. Roos et al. also found that none of the DNAm sites 
associated with these SNPs was associated with naevus count in 
their epigenome-wide association study (EWAS). Likewise, in our 
SMR analysis presence/absence of melanocytic naevi failed to co-
localize with any DNAm site.
Another study by Budden and Bowden described the regulation 
of MC1R expression by a CpG island overlapping a potential enhancer 
in the MC1R gene (Budden & Bowden, 2018). These authors found 
that this CpG island is unmethylated in melanocytes but highly meth-
ylated in other skin cell types. In addition, most of the melanoma 
cell lines and tumours examined in their study were methylated in 
this region. Further analysis indicated that differential methylation 
of the CpG island in tumours mainly affected the expression of 
MC1R, and less so of TUBB3. Budden and Bowden also reported that 
there was weak evidence of increasing CpG island methylation levels 
with increasing numbers of red hair colour alleles (R) in melanoma 
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tumours from The Cancer Genome Atlas (TCGA) dataset (Budden & 
Bowden, 2018).
While seven of the 12 MC1R SNPs that we evaluated were lo-
cated within the CpG island identified by Budden and Bowden, they 
were strongly associated with DNAm sites located nearby, although 
outside the island/enhancer region, making direct comparisons of 
results difficult.
Lastly, Martinez-Cadenas and colleagues (Martinez-Cadenas 
et al., 2013) postulated that the considerable nucleotide diversity 
evident at MC1R was probably the result of a high mutation rate 
that occurred as a consequence of the elevated CpG concentration 
present in the region. Chromosome 16q is also one of the richest re-
gions in gene and GC content, which has been found to be correlated 
(Zeng et al., 2018). In this study, polymorphisms in MC1R were asso-
ciated with DNAm variation at substantially more sites than is the 
case in other pigmentation genes, with lower GC content, tested (for 
instance, MC1R region SNPs are associated with 95 DNAm sites each 
on average, whereas ASIP region SNPs were associated with an aver-
age of 27 DNAm sites each, see Table 1).
From an evolutionary point of view, it is interesting to consider 
the potential for epigenetic modifications in pigmentation genes as 
a mechanism of adaptation to variable levels of ultraviolet radiation 
exposure, providing phenotypic flexibility in a changing environment, 
similar to what has been suggested for adaptation to high altitude 
(Julian, 2017). Since there is evidence that pigmentation genes, such 
as MC1R and ASIP, have been shaped by natural selection (Martinez-
Cadenas et al., 2013; Norton et al., 2007; Quillen et al., 2019), poly-
morphic variants in them may act, in part, by affecting how they are 
epigenetically regulated to optimize a response to an environment 
with reduced sunlight.
4.1 | Limitations
Our analysis was conducted on DNA derived from whole-blood 
rather than skin tissue, and any pigmentation SNP-DNAm site as-
sociations may not be as strong or present in skin. We used herit-
ability estimates provided by Hannon, Gorrie-Stone, et al. (2018) to 
assess the likelihood of the DNAm sites examined to vary in a similar 
way in different tissues. These authors reported a low contribution 
on average of additive genetic effects on DNAm across the genome 
(~16%) and a higher heritability of the sites that were correlated 
across tissues (median 71%). Since most of the DNAm sites (16/24) 
we analysed had heritability values > 50%, it is possible that the as-
sociations that we detected with pigmentation SNPs are also there 
in skin. Moreover, for two MC1R polymorphisms, Roos et al. (2017) 
already described an association in healthy skin with some of the 
same DNAm sites identified in our study. Although not examining 
mQTLs, Yuan et al. (2019) also reported an association of DNAm 
sites in 16q24.3 within the genes SPG7, DPEP1, FANCA and SPIRE2, 
TA B L E  3   DNA methylation sites identified in GoDMC that colocalized with the expression of genes which, in turn, colocalized with 
pigmentation/sun exposure/skin cancer phenotypes. These DNAm sites also colocalized with pigmentation/sun exposure/skin cancer 
phenotypes in an independent test
DNAm sites Chromosome
Associated pigmentation 
SNPs Colocalized genes Colocalized phenotypesa 
cg01901788 20q11.22 rs1015362, rs4911414, 
rs619865
NCOA6 skin colour, ease of skin tanning, blonde 
hair, black hair
cg04270048 20q11.22 rs4911414, rs619865 NCOA6 skin colour, ease of skin tanning, childhood 
sunburn, blonde hair, black hair
cg16810054 20q11.22 rs619865 NCOA6 blonde hair, black hair
cg04378830 16q24.3 rs2228479 DBNDD1, MC1R blonde hair, black hair, self-reported BCC
cg04752812 16q24.3 rs2228479 DBNDD1, DEF8 blonde hair, skin colour, ease of skin 
tanning, self-reported BCC
cg09569215 16q24.3 rs11648785, rs2228479, 
rs4785763
MC1R blonde hair, black hair
cg10062109 16q24.3 rs1805008, rs4785763 CDK10 blonde hair, black hair, self-reported 
melanoma, skin colour, ease of skin 
tanning, childhood sunburn, diagnosed 
melanoma, self-reported BCC
cg11215013 16q24.3 rs2228479 SPATA2L skin colour, black hair, self-reported 
melanoma
cg26598918 16q24.3 rs1805008, rs4785763 CDK10 blonde hair, black hair, skin colour, ease 
of skin tanning, childhood sunburn, 
diagnosed melanoma, self-reported BCC
Note: In bold: DNAm site followed up in this study.
aPhenotypes in red colocalized with the DNAm site shown in the first column, phenotypes in blue colocalized with the expression of the gene/s listed 
in the fourth column, and phenotypes in green colocalized with both, the DNAm site and gene expression. See Tables S6–S9 for the colocalization 
results. 
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which included cg04287289 and cg26513180, with ethnicity in pla-
cental tissue. However, the small overlap between the genes whose 
whole-blood expression was affected by the DNAm sites we tested 
and those whose expression in skin was associated with pigmenta-
tion and skin cancer phenotypes could be suggesting that there are 
in fact differences between tissues.
Unfortunately, mQTL data on populations of non-European 
ancestry are limited. In the only study involving one of these pop-
ulations that we identified, Pierce and colleagues reported an asso-
ciation of 5 of our pigmentation DNAm sites with SNPs in cis in the 
population of Bangladesh (Pierce et al., 2018). While this is an indica-
tion that similar genetic–epigenetic relationships are likely to occur 
in other groups, knowledge of the role of these chromosomal regions 
on pigmentation in non-White populations is still scarce (Pavan & 
Sturm, 2019).
Each of the methods we used has their own particular limitations, 
so it is advisable to be cautious in the interpretation of our findings.
The CIT method requires that the analysis is carried out in one 
sample where the SNP, exposure and outcome have all been mea-
sured, and therefore, statistical power is constrained by the size of 
this sample. It may also be affected by collider bias and phenotype 
measurement error. In order to protect against collider bias, it is es-
sential to adjust for all confounders of the exposure-outcome rela-
tionship. While we adjusted the regression models for age, sex and 
genetic principal components, unknown confounders may be still 
playing a role (Hemani et al., 2017).
The SMR method was conceived to try to tell apart pleiotropy 
from LD in the event of an association between gene expression 
and a complex trait, and thus to interpret results under a model of 
pleiotropy rather than causality, even though it could be consistent 
with the latter as well (Zhu et al., 2016). To tease out a causal effect, 
additional analyses are necessary, such as two-step Mendelian ran-
domization (Relton & Davey Smith, 2012) using independent (in cis 
or trans) mQTLs. However, independent instrumental variables for 
the DNAm sites in this study have been hard to find since there is 
usually considerable LD with the original SNPs. As a consequence, 
SMR results are mostly intended to be used to highlight genes for 
follow-up studies and not to establish unequivocal causal relation-
ships (Zhu et al., 2016).
In summary, our results suggest that DNAm may lie on the causal 
pathway leading from pigmentation-associated SNPs to pigmenta-
tion/sun exposure traits and eventually skin cancer, possibly via reg-
ulation of gene expression, although more evidence to support these 
findings is needed. This study puts forward a set of genes that could 
be prioritized in upcoming investigations (e.g. CDK10 or SPIRE2) to 
delve deeper into the role played by the variability in DNAm as a 
potentially causal risk factor for skin cancer. We have reported for 
the first time the existence of DNAm sites strongly influenced by 
genetic variants across pigmentation genes and demonstrated the 
importance of integrating different sources of variation and of un-
covering the interaction of markers within and between chromo-
somal regions (for instance, on chromosome 16 and chromosome 4) 
to obtain a better picture of pathways leading to disease. However, 
there is still some way to go before human genetic and epigenetic 
information can be introduced fully into the dermatology clinic for 
the provision of personalized medicine.
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